21. Ahern's BB 350 at Oregon State University - Translation II
822 views · Published 11 May 2017 · 47:08 · Indexed 10 November 2026
Channel: Kevin Ahern's YouTube Videos - Lectures and More · 2017 · Education
1. Contact - [email protected] 2. Kevin's lectures with The Great Courses - https://www.thegreatcoursesplus.com/biochemistry-and-molecular-biology-how-life-works?tn=Expert_tray_Course_1_0_12943 3. Kevin's Lecturio videos for medical students - https://www.lecturio.com/medical-courses/biochemistry.course 4. Course materials at https://kevingahern.com/biochemistry-resources/ 5. Course video channel at https://www.youtube.com/watch?v=JSntf0iKMfM&list=PLlnFrNM93wqz37TUabcXFSNX2nJtrJnkx Highlights Translation 2 1. In the elongation phase of translation, tRNAs enter the A site of the ribosome and must properly base pair with the codon in that site. The elongation factor EF-Tu plays an important role. EF-Tu is the most abundant E. coli protein and it functions to carry the tRNA to the A site of the ribosome. EF-Tu makes sure that the properly base-paired tRNA is in the A site. EF-Tu also protects the bond between the amino acid and the tRNA from water. 2. EF-Tu, like most of the initiation factors and elongation factors in translation, is a G-protein. These G-proteins get their name by carrying GTP and hydrolysing it as an energy source 3. Protein synthesis uses GTP as an energy source (not ATP). 4. A third site of the ribosome where tRNAs are found is the 'E site', which is where tRNAs exit the ribosome after they have been used. 5. Protein synthesis (translation) requires linking amino acids properly together via peptide bonds. Note that the growing polypeptide chain is held on a tRNA. After the peptide bond forms, the tRNA with the polypeptide chain moves to the P site and a new tRNA with an amino acid comes into the A site. This process also involves the mRNA sliding one codon down the chain to put a new codon in the A site. 6. After the tRNA properly binds in the A site, a peptide bond is formed between the peptide on the tRNA in the P site and the amino acid on the tRNA in the A site. The catalyst for the peptide bond is the 23S rRNAs in the ribosome. Thus, peptide bonds are formed by ribozymes (catalytic RNAs). The result is a peptide linked to the tRNA in the A site. 7. The next step in elongation occurs when the tRNA with the polypeptide in the A site moves over to the P site (displacing the tRNA previously there to the E site, from which it exits the ribosome). The A site is thus left open. The ribosome slides three nucleotides along the mRNA, bringing a new complementary sequence into the A site. Movement of the ribosome along the mRNA is facilitated by EF-G and requires GTP. 8. Translation is a target for action of antibiotics. This works because the structure of ribosomes in prokaryotes is different enough from that of eukaryotes that specific inhibitors of prokaryotic translation can be found that have no effect on eukaryotic translation. As a result, prokaryotes can be killed without any effect on eukaryotes taking said antibiotics. One translational inhibitor of prokaryotic translation is the antibiotic puromycin, which acts to prematurely terminate prokaryotic translation at the elongation phase. This happens because puromycin looks like a tRNA and fits into the A (or P) site of the ribosome. In the A site, it can be attached to the growing polypeptide chain, but it is soon released, causing premature termination. In addition, puromycin can bind to the P site of ribosomes and prevents anything from binding there. 9. Eukaryotic mRNAs have a 5' cap and a 3' polyA tail. Eukaryotic translation occurs much like prokaryotic translation, but the factors are differently named. One important difference of eukaryotic translation is that the initiation complex in eukaryotes involves both the 5' cap and the 3' polyA sequence in a looped structure. The 5' cap and 3' poly-A sequence both play roles in helping to increase the stability of eukaryotic mRNAs. 10. Post-translational (= after translation has occurred) processing of proteins gives them their final structure and properties. One such modification was discussed for insulin. This involves proteolytic cleavage at two places in the insulin precursor, giving rise to a final structure that has two chains held together by disulfide bonds. 11. Selenocysteine is a rare amino acid occasionally incorporated into proteins. It is sometimes called the 21st amino acid. It is the only modified amino acid in proteins that gets there by direct incorporation rather than post-translational modification. It is because of this that trace amounts of selenium are needed in the diet. 12. Proper folding of proteins is important. A complex in E. coli that facilitates proper folding of proteins is the GroES/GroEL complex, which provides a chamber for a protein to fold in without interference of other proteins during the folding process. Proteins such as GroES/GroEL are called chaperonins.
More from this channel
-
0:56
When Acids are Oxidized
-
0:30
How to do "The Wiggle", part 2
-
0:18
How to Do "The Wiggle", part 1
-
14:52
Water, Acids, and Buffers in Biochemistry by Kevin Ahern, Part 5 of 8
-
14:51
Water, Acids, and Buffers in Biochemistry by Kevin Ahern, Part 3 of 8
-
14:41
Amino Acid Structure and Charge by Kevin Ahern, Part 1 of 4
-
14:31
Amino Acid Structure and Charge by Kevin Ahern, Part 2 of 4
-
14:44
Protein Structure and Function by Kevin Ahern, Part 5 of 8